TPD: Difference between revisions

Consumers and healthcare professionals can report side effects and safety concerns with e-cigarettes or refill containers to<span></span><abbr title="The Medicines and Healthcare products Regulatory Agency">MHRA</abbr><span></span>through the<span></span>[https://yellowcard.mhra.gov.uk/ Yellow Card]<span></span>reporting system. You can also report products suspected to be defective or non-compliant to your local Trading Standards or to<span></span>[mailto:TPDsafety@mhra.gov.uk TPDsafety@mhra.gov.uk].The UK<span></span>[http://www.legislation.gov.uk/uksi/2016/507/contents/made Tobacco and Related Products Regulations 2016]<span></span>implement the<span></span><abbr title="Tobacco Products Directive">TPD</abbr><span></span>in the UK, and came into force on 20 May 2016.<span></span>[http://www.legislation.gov.uk/uksi/2016/507/part/6/made Part 6]<span></span>of the regulations sets out the requirements for e-cigarettes and refill containers.The regulations introduce requirements for producers of e-cigarettes and refill containers. A producer is anyone who manufactures or imports these products or who re-brands any product as their own. Producers must submit information about their products to<span></span><abbr title="The Medicines and Healthcare products Regulatory Agency">MHRA</abbr><span></span>through a European Common Entry Gate (EU-CEG) notification portal.Retailers do not need to submit information for any products they sell unless they also qualify as a producer. Retailers had until 20 May 2017 to sell through stock of products that do not comply with the labelling and product composition requirements of the<span></span><abbr title="Tobacco Products Directive">TPD</abbr>.The<span></span><abbr title="Tobacco Products Directive">TPD</abbr><span></span>does not cover nicotine-containing products that are authorised as medicines. Further information about licensing these products as medicines can be found<span></span>[https://www.gov.uk/government/publications/licensing-procedure-for-electronic-cigarettes-and-other-nicotine-containing-products-ncps-as-medicines here]